Which sections of the Body20 Franchise Agreement are amended by the addition described in this Rider?

According to the 2025 Body20 Franchise Disclosure Document, the Rider to the Franchise Agreement for use in Maryland amends specific sections of the Franchise Agreement. Specifically, it adds a provision to the end of Sections 2.2(d) ("Successor Term"), 13.4(d) ("Control Transfer"), 13.5 ("Non-Control Transfers"), 13.6 ("Transfer To an Entity"), and 15.7(d) ("Closing"). This addition stipulates that the general release required as a condition of renewal, sale, and/or assignment/transfer will not apply to any liability arising under the Maryland Franchise Registration and Disclosure Law.

Similarly, the Rider to the Franchise Agreement for use in New York modifies several sections. It adds provisions to the end of Sections 2.2(d), 4.3, 4.5, 13.4(d), 13.5, 13.6, and 15.7(d), clarifying that rights and causes of action under Article 33 of the General Business Law of New York remain in force. Additionally, it adds to the end of Section 14.3, allowing the franchisee to terminate the agreement on grounds available under Article 33 of the General Business Law of New York. Furthermore, it adds statements to Sections 16.1 and 16.3(d) to ensure no waiver of rights conferred by Article 33 and adds to the end of Section 16.8 to reinforce the non-waiver provisions of GBL Sections 687.4 and 687.5.

For franchisees in Illinois, Section 16.1 of the Franchise Agreement is deleted and replaced within the Rider, and language is added to the end of Section 16.3(d). For franchisees in North Dakota, Section 16.4 of the Franchise Agreement is deleted to the extent required by the North Dakota Franchise Investment Law. For franchisees in Rhode Island, language is added to the end of Sections 16.1 and 16.3(d) of the Franchise Agreement.